We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging DBV Technologies (DBVT) This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. DBV Technologies S.A. (DBVT - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
DBV Technologies S.A. is one of 999 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. DBV Technologies S.A. is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for DBVT's full-year earnings has moved 78.9% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, DBVT has gained about 210.7% so far this year. At the same time, Medical stocks have lost an average of 4.4%. This means that DBV Technologies S.A. is outperforming the sector as a whole this year.
Hims & Hers Health, Inc. (HIMS - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 153.1%.
Over the past three months, Hims & Hers Health, Inc.'s consensus EPS estimate for the current year has increased 37.9%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, DBV Technologies S.A. belongs to the Medical - Biomedical and Genetics industry, which includes 506 individual stocks and currently sits at #70 in the Zacks Industry Rank. Stocks in this group have lost about 4.3% so far this year, so DBVT is performing better this group in terms of year-to-date returns.
On the other hand, Hims & Hers Health, Inc. belongs to the Medical Info Systems industry. This 38-stock industry is currently ranked #70. The industry has moved +16.9% year to date.
Investors interested in the Medical sector may want to keep a close eye on DBV Technologies S.A. and Hims & Hers Health, Inc. as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging DBV Technologies (DBVT) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. DBV Technologies S.A. (DBVT - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
DBV Technologies S.A. is one of 999 companies in the Medical group. The Medical group currently sits at #4 within the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. DBV Technologies S.A. is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for DBVT's full-year earnings has moved 78.9% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, DBVT has gained about 210.7% so far this year. At the same time, Medical stocks have lost an average of 4.4%. This means that DBV Technologies S.A. is outperforming the sector as a whole this year.
Hims & Hers Health, Inc. (HIMS - Free Report) is another Medical stock that has outperformed the sector so far this year. Since the beginning of the year, the stock has returned 153.1%.
Over the past three months, Hims & Hers Health, Inc.'s consensus EPS estimate for the current year has increased 37.9%. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, DBV Technologies S.A. belongs to the Medical - Biomedical and Genetics industry, which includes 506 individual stocks and currently sits at #70 in the Zacks Industry Rank. Stocks in this group have lost about 4.3% so far this year, so DBVT is performing better this group in terms of year-to-date returns.
On the other hand, Hims & Hers Health, Inc. belongs to the Medical Info Systems industry. This 38-stock industry is currently ranked #70. The industry has moved +16.9% year to date.
Investors interested in the Medical sector may want to keep a close eye on DBV Technologies S.A. and Hims & Hers Health, Inc. as they attempt to continue their solid performance.